Koyfin Home > Directory > Health Care > Acorda Therapeutics

Acorda Therapeutics Price Chart ACOR

Historical daily share price chart and data for Acorda Therapeutics since 2006 adjusted for splits and dividends. The latest closing price for Acorda Therapeutics as of October 20, 2020 is $0.962.
  • In 2020 the stock opened at $2.09 and closed at $0.96 for a loss of -117% YTD.
  • In 2019 the stock opened at $15.26 and closed at $2.04 for a loss of -648%.
  • In 2018 the stock opened at $21.70 and closed at $15.58 for a loss of -39%.
  • In 2017 the stock opened at $18.90 and closed at $21.45 for a gain of 12%.
View Chart On Koyfin

Acorda Therapeutics Summary

Stock Symbol: ACOR

Acorda Therapeutics Company Info

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Selincro, an orally administered drug for the treatment of alcohol dependence in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops Inbrija for the treatment of OFF periods in Parkinson’s disease and ARCUS product for the treatment of acute migraine. Further, it develops rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa that is in Phase Ib clinical trial for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
1260.29 %
30D Volatility
Hedge Fund Held
25.15 %

Last 10 Days of ACOR Prices